Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401
Condition: Intervention: Drug: omaveloxolone Sponsor: Reata Pharmaceuticals, Inc. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Melanoma | Skin Cancer